4/A

FORM 4/A SUBMISSION

Company: Sensei Biotherapeutics, Inc.
Filed: March 29, 2023
Period of Report: February 15, 2023
Accession Number: 0001209191-23-021541

View Document ↗ View on SEC.gov ↗